Migraine Drugs Market Report by Treatment Type (Abortive Treatment, Preventive Treatment), Drug Type (Triptans, Ergot Alkaloids, NSAIDs, Acetylcholine Inhibitors/ Neurotoxins, Ditans, CGRP mAbs, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital-Based Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033

Migraine Drugs Market Report by Treatment Type (Abortive Treatment, Preventive Treatment), Drug Type (Triptans, Ergot Alkaloids, NSAIDs, Acetylcholine Inhibitors/ Neurotoxins, Ditans, CGRP mAbs, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital-Based Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2543

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Migraine Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Treatment Type
    6.1    Abortive Treatment
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Preventive Treatment
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Drug Type
    7.1    Triptans
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Ergot Alkaloids
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    NSAIDs
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Acetylcholine Inhibitors/ Neurotoxins
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Ditans
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    CGRP mAbs
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Others
        7.7.1 Market Trends
        7.7.2 Market Forecast
8   Market Breakup by Route of Administration
    8.1    Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectable
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Hospital-Based Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Allergan Plc (Abbvie Inc.)
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
           15.3.2.3 SWOT Analysis
        15.3.3    Amgen Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 SWOT Analysis
        15.3.4    AstraZeneca Plc
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Eisai Co. Ltd.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Eli Lilly and Company
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Endo International Plc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    GlaxoSmithKline Plc
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Johnson & Johnson
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Merck & Co.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Novartis AG
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio 
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis
        15.3.13    Pfizer Inc.
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio 
           15.3.13.3 Financials
           15.3.13.4 SWOT Analysis
        15.3.14    Sanofi SA
           15.3.14.1 Company Overview
           15.3.14.2 Product Portfolio 
           15.3.14.3 Financials
           15.3.14.4 SWOT Analysis
        15.3.15    Teva Pharmaceutical Industries Limited
           15.3.15.1 Company Overview
           15.3.15.2 Product Portfolio 
           15.3.15.3 Financials
           15.3.15.4 SWOT Analysis

List of Figures

Figure 1: Global: Migraine Drugs Market: Major Drivers and Challenges
Figure 2: Global: Migraine Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Migraine Drugs Market: Breakup by Treatment Type (in %), 2024
Figure 4: Global: Migraine Drugs Market: Breakup by Drug Type (in %), 2024
Figure 5: Global: Migraine Drugs Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Migraine Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Migraine Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Migraine Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Migraine Drugs (Abortive Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Migraine Drugs (Abortive Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Migraine Drugs (Preventive Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Migraine Drugs (Preventive Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Migraine Drugs (Triptans) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Migraine Drugs (Triptans) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Migraine Drugs (Ergot Alkaloids) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Migraine Drugs (Ergot Alkaloids) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Migraine Drugs (NSAIDs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Migraine Drugs (NSAIDs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Migraine Drugs (Acetylcholine Inhibitors/ Neurotoxins) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Migraine Drugs (Acetylcholine Inhibitors/ Neurotoxins) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Migraine Drugs (Ditans) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Migraine Drugs (Ditans) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Migraine Drugs (CGRP mAbs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Migraine Drugs (CGRP mAbs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Migraine Drugs (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Migraine Drugs (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Migraine Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Migraine Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Migraine Drugs (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Migraine Drugs (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Migraine Drugs (Other Routes of Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Migraine Drugs (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Migraine Drugs (Hospital-Based Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Migraine Drugs (Hospital-Based Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Migraine Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Migraine Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Migraine Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Migraine Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: North America: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: North America: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: United States: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: United States: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Canada: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Canada: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Asia Pacific: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Asia Pacific: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: China: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: China: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Japan: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Japan: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: India: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: India: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: South Korea: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: South Korea: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Australia: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Australia: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Indonesia: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Indonesia: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Others: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Others: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Europe: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Europe: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Germany: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Germany: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: France: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: France: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: United Kingdom: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: United Kingdom: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Italy: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Italy: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Spain: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Spain: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Russia: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Russia: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Others: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Others: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Latin America: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Latin America: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Brazil: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Brazil: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Mexico: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Mexico: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Others: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Others: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Middle East and Africa: Migraine Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Middle East and Africa: Migraine Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Global: Migraine Drugs Industry: SWOT Analysis
Figure 88: Global: Migraine Drugs Industry: Value Chain Analysis
Figure 89: Global: Migraine Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Migraine Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Migraine Drugs Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
Table 3: Global: Migraine Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 4: Global: Migraine Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 5: Global: Migraine Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Migraine Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Migraine Drugs Market Structure
Table 8: Global: Migraine Drugs Market: Key Players

Migraine Drugs Market Report by Treatment Type (Abortive Treatment, Preventive Treatment), Drug Type (Triptans, Ergot Alkaloids, NSAIDs, Acetylcholine Inhibitors/ Neurotoxins, Ditans, CGRP mAbs, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital-Based Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials